CVD May Increase Risk of Cognitive Decline in Older Women

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A relationship between cardiovascular disease (CVD) and cognitive decline in postmenopausal women was identified in a recent study published online in the Journal of the American Heart Association. In women without CVD, hypertension and diabetes increased the risk for cognitive decline. No significant relationship was found between atrial fibrillation and heart failure with cognitive functioning.

To read the full article at HCPLive.com, click here
Related Articles
With obesity on the rise, the FDA recently approved another weight-loss medication.
Almost all women and seniors with atrial fibrillation should be receiving blood thinners, advises a new analysis of updated clinical practice guidelines.
Sanofi has announced the FDA approval of its insulin glargine injection (Toujeo), a once-daily long-acting basal insulin, for the improvement of glycemic control in adults with type 1 and type 2 diabetes.
The FDA recently granted priority review to Novarits’ investigational drug LCZ696, a potential treatment for heart failure with ejection fraction.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$